BridgeMD
New treatment option for Cervical Myelopathy
Official title Quatitative MRI of the Spinal Cord in Cervical Myelopathy: Assessment of Microstuctural Damage for Outcome Improvement
ClinicalTrials.gov ID: NCT06486038
What this study is testing
- What it's testing
- The aim of this low interventional study is to detect microstructural degeneration prior to the presentation, worsening, or persistence following surgical or conservative treatment of cervical degenerative myelopathy signs and symptoms using quantitative imaging metrics and functional biometric analysis. The endpoints of the study are to collect and compare the clinical, biometric, neurophysiological and imaging data.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 80
You may be able to join if
- people willing and able to give informed consent for participation in the study.
- Age 18-80.
- people under evaluation for potential surgical intervention of anterior cervical discectomy and fusion as established by a board-certified...
- Grade I-III single level sub-axial (C3-C7) cervical spinal canal stenosis (Kang, AJR 2011) on a preliminary anatomical MRI.
- Deficitary or irritative cervical spinal cord symptoms and/or signs in concordance with MRI findings.
You likely can't join if
- people unable o.r unwilling to give informed consent .
- Age \ 80
- people with pacemaker or any other contraindication to undergo high-field (3 Tesla) MRI exam.
- Pregnancy or planned pregnancy before the end of the study .
- Co-existing or prior neurological disease of the brain, SC, or peripheral nervous system.
- Co-existing or prior oncologic disease .
See the full eligibility criteria
- people willing and able to give informed consent for participation in the study.
- Age 18-80.
- people under evaluation for potential surgical intervention of anterior cervical discectomy and fusion as established by a board-certified neurosurgeon based on clinical and radiological findings according to good...
- Grade I-III single level sub-axial (C3-C7) cervical spinal canal stenosis (Kang, AJR 2011) on a preliminary anatomical MRI.
- Deficitary or irritative cervical spinal cord symptoms and/or signs in concordance with MRI findings.
- people unable o.r unwilling to give informed consent .
- Age \ 80
- people with pacemaker or any other contraindication to undergo high-field (3 Tesla) MRI exam.
- Pregnancy or planned pregnancy before the end of the study .
- Co-existing or prior neurological disease of the brain, SC, or peripheral nervous system.
- Co-existing or prior oncologic disease .
- Prior surgery in the brain or spine.
The study team makes the final eligibility decision.
Where it's taking place
- Rozzano, Italy
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Rozzano, Italy. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.